SYBR Green–based quantitation of human T-lymphotropic virus type 1 proviral load in Peruvian patients with neurological disease and asymptomatic carriers: Influence of clinical status, sex, and familial relatedness

References

• Albrecht B, Collins N D, Newbound G C, Ratner L, Lairmore M D. Quantification of human T-cell lymphotropic virus type 1 proviral load by quantitative competitive polymerase chain reaction. J Virol Methods 1998; 75: 123–40, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Asquith B, Mosley A J, Barfield A, Marshall S E, Heaps A, Goon P, Hanon E, Tanaka Y, Taylor G P, Bangham C R. A functional CD8+ cell assay reveals individual variation in CD8+ cell antiviral efficacy and explains differences in human T-lymphotropic virus type 1 proviral load. J Gen Virol 2005a; 86: 1515–1523, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Asquith B, Mosley A J, Heaps A, Tanaka Y, Taylor G P, McLean A R, Bangham C R. Quantification of the virus-host interaction in human T-lymphotropic virus I infection. Retrovirology 2005b; 2: 75, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Cimarelli A, Duclos C A, Gessain A, Cattaneo E, Casoli C, Biglione M, Mauclere P, Bertazzoni U. Quantification of HTLV-II proviral copies by competitive polymerase chain reaction in peripheral blood mononuclear cells of Italian injecting drug users, central Africans, and Amerindians. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 10: 198–204, [INFOTRIEVE], [CSA]
   Google Scholar
• Dehée A, Césaire R, Désiré N, Lézin A, Bourdonné O, Béra O, Plumelle Y, Smadja D, Nicolas J C. Quantitation of HTLV-I proviral load by a TaqMan real-time PCR assay. J Virol Methods 2002; 102: 37–51, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• de The G, Bomford R. An HTLV-I vaccine: why, how, for whom?. AIDS Res Hum Retroviruses 1993; 9: 381–386, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Dumas M, Houinato D, Verdier M, Zohoun T, Josse R, Bonis J, Zohoun I, Massougbodji A, Denis F. Seroepidemiology of human T-cell lymphotropic virus type I/II in Benin (West Africa). AIDS Res Hum Retroviruses 1991; 7: 447–451, [INFOTRIEVE], [CSA]
   Google Scholar
• Estes M C, Sevall J S. Multiplex PCR using real-time DNA amplification for the rapid detection and quantitation of HTLV-I or II. Mol Cell Probes 2003; 17: 59–68, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Gessain A, Barin F, Vernant J C, Gout O, Maurs L, Calender A, de The G. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985; 2: 407–410, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Gessain A, Gout O. Chronic myelopathy associated with human T-lymphotropic virus type I (HTLV-I). Ann Intern Med 1992; 117: 933–946, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Gotuzzo E, Arango C, de Queiroz-Campos A, Isturiz R E. Human T-cell lymphotropic virus-I in Latin America. Infect Dis Clin North Am 2000; 14: 211–239, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Gotuzzo E, Cabrera J, Deza L, Verdonck K, Vandamme A M, Cairampoma R, Vizcarra D, Cabada M, Narvarte G, De las Casas C. Clinical characteristics of patients in Peru with human T cell lymphotropic virus type 1-associated tropical spastic paraparesis. Clin Infect Dis 2004; 39: 939–944, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Hanada S, Uematsu T, Iwahashi M, Nomura K, Utsunomiya A, Kodama M, Ishibashi K, Terada A, Saito T, Makino T, et al. The prevalence of human T-cell leukemia virus type I infection in patients with hematologic and nonhematologic diseases in an adult T-cell leukemia-endemic area of Japan. Cancer 1989; 64: 1290–1295, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Harrington W J, Jr, Sheremata W A, Snodgrass S R, Emerson S, Phillips S, Berger J R. Tropical spastic paraparesis/ HTLV-1–associated myelopathy (TSP/HAM): treatment with an anabolic steroid danazol. AIDS Res Hum Retroviruses 1991; 7: 1031–1034, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Hinuma Y, Nagata K, Hanaoka M, Nakai M, Matsumoto T, Kinoshita K I, Shirakawa S, Miyoshi I. Adult-T cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci U S A 1981; 78: 6476–6480, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Ishihara S, Okayama A, Stuver S, Horinouchi H, Shioiri S, Murai K, Kubota T, Yamashita R, Tachibana N, Tsubouchi H, et al. Association of HTLV-I antibody profile of asymptomatic carriers with proviral DNA levels of peripheral blood mononuclear cells. J Acquir Immune Defic Syndr 1994; 7: 199–203, [INFOTRIEVE], [CSA]
   Google Scholar
• Jacobson S, Shida H, McFarlin D E, Fauci A S, Koenig S. Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I-associated neurological disease. Nature 1990; 348: 245–248, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Jeffery K J, Siddiqui A A, Bunce M, Lloyd A L, Vine A M, Witkover A D, Izumo S, Usuku K, Welsh K I, Osame M, Bangham C R. The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection. J Immunol 2000; 165: 7278–7284, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Jeffery K J, Usuku K, Hall S E, Matsumoto W, Taylor G P, Procter J, Bunce M, Ogg G S, Welsh K I, Weber J N, et al. HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc Natl Acad Sci U S A 1999; 96: 3848–3853, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Kamihira S, Dateki N, Sugahara K, Hayashi T, Harasawa H, Minami S, Hirakata Y, Yamada Y. Significance of HTLV-1 proviral load quantification by real-time PCR as a surrogate marker for HTLV-1–infected cell count. Clin Lab Haem 2003; 25: 111–117, [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Kaplan J E, Osame M, Kubota H, Igata A, Nishitani H, Maeda Y, Khabbaz R F, Janssen R S. The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I. J Acquir Immune Defic Syndr 1990; 3: 1096–1101, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Kira J, Koyanagi Y, Yamada T, Itoyama Y, Goto I, Yamamoto N, Sasaki H, Sakaki Y. Increased HTLV-I proviral DNA in HTLV-I-associated myelopathy: a quantitative polymerase chain reaction study. Ann Neurol 1991; 29: 194–201, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Kira J, Nakamura M, Sawada T, Koyanagi Y, Ohori N, Itoyama Y, Yamamoto N, Sakaki Y, Goto I. Antibody titers to HTLV-I-p40tax protein and gag-env hybrid protein in HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with increased HTLV-I proviral DNA load. J Neurol Sci 1992; 107: 98–104, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Kubota R, Fujiyoshi T, Izumo S, Yashiki S, Maruyama I, Osame M, Sonoda S. Fluctuation of HTLV-I proviral DNA in peripheral blood mononuclear cells of HTLV-I-associated myelopathy. J Neuroimmunol 1993; 42: 147–154, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Kurtzke J F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444–1452, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Lee T H, Chafets D M, Busch M P, Murphy E L. Quantitation of HTLV-I and II proviral load using real-time quantitative PCR with SYBR Green chemistry. J Clin Virol 2004; 31: 275–282, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Lima M A, Bica R B, Araújo A Q. Gender influence on the progression of HTLV-I-associated myelopathy/tropical spastic paraparesis. J Neurol Neurosurg Psychiatry 2005; 76: 294–296, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Mackay I M, Arden K E, Nitsche A. Real-time PCR in virology. Nucleic Acids Res 2002; 30: 1292–1305, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Mahoney F I, Barthel D W. Functional evaluation: the Barthel Index. Md State Med J 1965; 14: 61–65, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Maloney E M, Cleghorn F R, Morgan O S, Rodgers-Johnson P, Cranston B, Jack N, Blattner W A, Bartholomew C, Manns A. Incidence of HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Jamaica and Trinidad. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 17: 167–170, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Matsuzaki T, Nakagawa M, Nagai M, Usuku K, Higuchi I, Arimura K, Kubota H, Izumo S, Akiba S, Osame M. HTLV-I proviral load correlates with progression of motor disability in HAM/TSP: analysis of 239 HAM/TSP patients including 64 patients followed up for 10 years. J NeuroVirol 2001; 7: 228–234, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Miley W J, Suryanarayana K, Manns A, Kubota R, Jacobson S, Lifson J D, Waters D. Real-time polymerase chain reaction assay for cell-associated HTLV type I DNA viral load. AIDS Res Hum Retroviruses 2000; 16: 665–675, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Miyoshi I, Kubonishi I, Yoshimoto S, Akagi T, Ohtsuki Y, Shiraishi Y, Nagata K, Hinuma Y. Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells. Nature 1981; 294: 770–771, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Montanheiro P A, Oliveira A C, Posada-Vergara M P, Milagres A C, Tauil C, Marchiori P E, Duarte A J, Casseb J. Human T-cell lymphotropic virus type I (HTLV-I) proviral DNA viral load among asymptomatic patients and patients with HTLV-I-associated myelopathy/tropical spastic paraparesis. Braz J Med Biol Res 2005; 38: 1643–1647, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Murphy E L, Figueroa J P, Gibbs W N, Holding-Cobham M, Cranston B, Malley K, Bodner A J, Alexander S S, Blattner W A. Human T-lymphotropic virus type I (HTLV-I) seroprevalence in Jamaica. I. Demographic determinants. Am J Epidemiol 1991; 133: 1114–1124, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Murphy E L, Hanchard B, Figueroa J P, Gibbs W N, Lofters W S, Campbell M, Goedert J J, Blattner W A. Modelling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I. Int J Cancer 1989; 43: 250–253, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Nagai M, Brennan M B, Sakai J A, Mora C A, Jacobson S. CD8(+) T cells are an in vivo reservoir for human T-cell lymphotropic virus type I. Blood 2001; 98: 1858–1861, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Nagai M, Usuku K, Matsumoto W, Kodama D, Takenouchi N, Moritoyo T, Hashiguchi S, Ichinose M, Bangham C R, Izumo S, Osame M. Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. J NeuroVirol 1998; 4: 586–593, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Nicot C, Astier-Gin T, Edouard E, Legrand E, Moynet D, Vital A, Londos-Gagliardi D, Moreau J P, Guillemain B. Establishment of HTLV-I-infected cell lines from French, Guianese and West Indian patients and isolation of a proviral clone producing viral particles. Virus Res 1993; 30: 317–334, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Olindo S, Lézin A, Cabre P, Merle H, Saint-Vil M, Edimonana Kaptue M, Signate A, Césaire R, Smadja D. HTLV-1 proviral load in peripheral blood mononuclear cells quantified in 100 HAM/TSP patients: a marker of disease progression. J Neurol Sci 2005; 237: 53–59, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Osame M. Review of WHO Kagoshima meeting and diagnostic guidelines for HAM/TSP. Human retrovirology: HTLV, W A Blattner. Raven Press, New York 1990; 191–197
   Google Scholar
• Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, Matsumoto M, Tara M. HTLV-I associated myelopathy, a new clinical entity. Lancet 1986; 1: 1031–1032, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Ouattara S A, Gody M, de The G. Prevalence of HTLV-I compared to HIV-1 and HIV-2 antibodies in different groups in the Ivory Coast (West Africa). J Acquir Immune Defic Syndr 1989; 2: 481–485, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Papin J F, Vahrson W, Dittmer D P. SYBR Green-based real-time quantitative PCR assay for detection of West Nile Virus circumvents false-negative results due to strain variability. J Clin Microbiol 2004; 42: 1511–1518, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Parker C E, Daenke S, Nightingale S, Bangham C R. Activated, HTLV-1–specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis. Virology 1992; 188: 628–636, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Poiesz B J, Ruscetti F W, Gazdar A F, Bunn P A, Minna J D, Gallo R C. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A 1980; 77: 7415–7419, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Proietti F A, Carneiro-Proietti A B, Catalan-Soares B C, Murphy E L. Global epidemiology of HTLV-I infection and associated diseases. Oncogene 2005; 24: 6058–6068, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Takenouchi N, Yamano Y, Usuku K, Osame M, Izumo S. Usefulness of proviral load measurement for monitoring of disease activity in individual patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis. J NeuroVirol 2003; 9: 29–35, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Taylor G P, Tosswill J H, Matutes E, Daenke S, Hall S, Bain B J, Davis R, Thomas D, Rossor M, Bangham C R, Weber J N. Prospective study of HTLV-I infection in an initially asymptomatic cohort. J Acquir Immune Defic Syndr 1999; 22: 92–100, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Vine A M, Heaps A G, Kaftantzi L, Mosley A, Asquith B, Witkover A, Thompson G, Saito M, Goon P K, Carr L, et al. The role of CTLs in persistent viral infection: cytolytic gene expression in CD8+ lymphocytes distinguishes between individuals with a high or low proviral load of human T cell lymphotropic virus type 1. J Immnunol 2004; 173: 5121–5129, [CSA]
   PubMed Web of Science ®Google Scholar
• Vitone F, Gibellini D, Schiavone P, D'Antuono A, Gianni L, Bon I, Re M C. Human T-lymphotropic virus type 1 (HTLV-1) prevalence and quantitative detection of DNA proviral load in individuals with indeterminate/positive serological results. BMC Infect Dis 2006; 6: 41, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Yamano Y, Nagai M, Brennan M, Mora C A, Soldan S S, Tomaru U, Takenouchi N, Izumo S, Osame M, Jacobson S. Correlation of human T-cell lymphotropic virus type 1 (HTLV-1) mRNA with proviral DNA load, virus-specific CD8(+) T cells, and disease severity in HTLV-1–associated myelopathy (HAM/TSP). Blood 2002; 99: 88–94, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Yuan C C, Miley W, Waters D. A quantification of human cells using an ERV-3 real time PCR assay. J Virol Methods 2001; 91: 109–117, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar